HEC-866

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameHEC-866
Drug Alias NameHEC-866
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP38 γ mitogen-activated protein kinase inhibitors
TargetsP38 γ mitogen-activated protein kinase
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDongguan Dongguan Sunshine Pharmaceutical Research and Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDongguan Dongguan Sunshine Pharmaceutical Research and Development Co Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A